Results
high-density lipoprotein-cholesterol, GDM
GDM, INSULIN RESISTANCE
Between January 2019 and February 2021, 154 participants were randomly assigned to the CGM group (n=77) or SMBG group (n=77). The study outcome visit was completed by 62 participants (82.7%) in the CGM group and 62 (82.7%) in the SMBG group (Demographic and metabolic characteristics of GDM patients at baseline.Data are expressed as mean ± SD or median (interquartile range) or n (%). pre-BMI, body mass index before pregnancy; FPG, fasting plasma glucose; 1hPG, 1-h plasma glucose; 2hPG, 2-h plasma glucose; FINS, fasting insulin; 1hINS, 1-h insulin; 2hINS, 2-h insulin; HbA1c, hemoglobin A1c; GA, glycated albumin; HOMA-IR, homeostasis model assessment for insulin resistance index; HOMA-β, homeostasis model assessment for β-cell function, TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol.